Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Consequences of chronic kidney disease in chronic obstructive pulmonary disease.

Trudzinski FC, Alqudrah M, Omlor A, Zewinger S, Fliser D, Speer T, Seiler F, Biertz F, Koch A, Vogelmeier C, Welte T, Watz H, Waschki B, Fähndrich S, Jörres R, Bals R; German COSYCONET consortium.

Respir Res. 2019 Jul 12;20(1):151. doi: 10.1186/s12931-019-1107-x.

2.

Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort.

Trudzinski FC, Kahnert K, Vogelmeier CF, Alter P, Seiler F, Fähndrich S, Watz H, Welte T, Speer T, Zewinger S, Biertz F, Kauczor HU, Jörres RA, Bals R; COSYCONET consortium.

Respir Med. 2019 Jul - Aug;154:18-26. doi: 10.1016/j.rmed.2019.06.007. Epub 2019 Jun 11.

PMID:
31203096
3.

Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study.

Schunk SJ, Zarbock A, Meersch M, Küllmar M, Kellum JA, Schmit D, Wagner M, Triem S, Wagenpfeil S, Gröne HJ, Schäfers HJ, Fliser D, Speer T, Zewinger S.

Lancet. 2019 Aug 10;394(10197):488-496. doi: 10.1016/S0140-6736(19)30769-X. Epub 2019 Jun 12.

PMID:
31202596
4.

Hyperkalaemia in Heart Failure-Pathophysiology, Implications and Therapeutic Perspectives.

Llubani R, Vukadinović D, Werner C, Marx N, Zewinger S, Böhm M.

Curr Heart Fail Rep. 2018 Dec;15(6):390-397. doi: 10.1007/s11897-018-0413-9. Review.

PMID:
30421355
5.

Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.

Zewinger S, Rauen T, Rudnicki M, Federico G, Wagner M, Triem S, Schunk SJ, Petrakis I, Schmit D, Wagenpfeil S, Heine GH, Mayer G, Floege J, Fliser D, Gröne HJ, Speer T.

J Am Soc Nephrol. 2018 Nov;29(11):2722-2733. doi: 10.1681/ASN.2018040405. Epub 2018 Oct 2.

PMID:
30279273
6.

Potassium: an ion with dangerous airs and graces.

Speer T, Schunk SJ, Zewinger S.

Eur Heart J. 2018 May 1;39(17):1543-1545. doi: 10.1093/eurheartj/ehy159.

PMID:
29579264
7.

The new SFB/TRR219 Research Centre.

Noels H, Boor P, Goettsch C, Hohl M, Jahnen-Dechent W, Jankowski V, Kindermann I, Kramann R, Lehrke M, Linz D, Maack C, Niemeyer B, Roma LP, Schuett K, Speer T, Wagenpfeil S, Werner C, Zewinger S, Böhm M, Marx N, Floege J, Fliser D, Jankowski J.

Eur Heart J. 2018 Mar 21;39(12):975-977. doi: 10.1093/eurheartj/ehy083. No abstract available.

PMID:
29579229
8.

High-density lipoprotein (HDL) and infections: a versatile culprit.

Speer T, Zewinger S.

Eur Heart J. 2018 Apr 7;39(14):1191-1193. doi: 10.1093/eurheartj/ehx734. No abstract available.

PMID:
29240892
9.

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.

Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Koenig W, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, Blankenberg S, Waldeyer C, Sinning C, Schnabel RB, Lackner KJ, Vlachopoulou E, Nygård O, Svingen GFT, Pedersen ER, Tell GS, Sinisalo J, Nieminen MS, Laaksonen R, Trompet S, Smit RAJ, Sattar N, Jukema JW, Groesdonk HV, Delgado G, Stojakovic T, Pilbrow AP, Cameron VA, Richards AM, Doughty RN, Gong Y, Cooper-DeHoff R, Johnson J, Scholz M, Beutner F, Thiery J, Smith JG, Vilmundarson RO, McPherson R, Stewart AFR, Cresci S, Lenzini PA, Spertus JA, Olivieri O, Girelli D, Martinelli NI, Leiherer A, Saely CH, Drexel H, Mündlein A, Braund PS, Nelson CP, Samani NJ, Kofink D, Hoefer IE, Pasterkamp G, Quyyumi AA, Ko YA, Hartiala JA, Allayee H, Tang WHW, Hazen SL, Eriksson N, Held C, Hagström E, Wallentin L, Åkerblom A, Siegbahn A, Karp I, Labos C, Pilote L, Engert JC, Brophy JM, Thanassoulis G, Bogaty P, Szczeklik W, Kaczor M, Sanak M, Virani SS, Ballantyne CM, Lee VV, Boerwinkle E, Holmes MV, Horne BD, Hingorani A, Asselbergs FW, Patel RS; GENIUS-CHD consortium, Krämer BK, Scharnagl H, Fliser D, März W, Speer T.

Lancet Diabetes Endocrinol. 2017 Jul;5(7):534-543. doi: 10.1016/S2213-8587(17)30096-7. Epub 2017 May 26.

10.

Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.

Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, Petrakis I, Dressel A, Lepper PM, Scharnagl H, Ritsch A, Thorand B, Heier M, Meisinger C, de Las Heras Gala T, Koenig W, Wagenpfeil S, Schwedhelm E, Böger RH, Laufs U, von Eckardstein A, Landmesser U, Lüscher TF, Fliser D, März W, Meinitzer A, Speer T.

Eur Heart J. 2017 May 21;38(20):1597-1607. doi: 10.1093/eurheartj/ehx118.

PMID:
28379378
11.

HDL cholesterol: reappraisal of its clinical relevance.

März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U.

Clin Res Cardiol. 2017 Sep;106(9):663-675. doi: 10.1007/s00392-017-1106-1. Epub 2017 Mar 24. Review.

12.

[Clinical importance of HDL cholesterol].

März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U.

Herz. 2017 Feb;42(1):58-66. doi: 10.1007/s00059-016-4499-0. Epub 2016 Nov 14. Review. German.

PMID:
27844137
13.

Innate immunity in CKD-associated vascular diseases.

Zewinger S, Schumann T, Fliser D, Speer T.

Nephrol Dial Transplant. 2016 Nov;31(11):1813-1821. Epub 2015 Oct 9. Review.

PMID:
26454223
14.

Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1: Impact on Arterial Thrombus Formation In Vivo.

Holy EW, Akhmedov A, Speer T, Camici GG, Zewinger S, Bonetti N, Beer JH, Lüscher TF, Tanner FC.

J Am Coll Cardiol. 2016 Oct 11;68(15):1664-1676. doi: 10.1016/j.jacc.2016.07.755.

15.

Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.

Zewinger S, Drechsler C, Kleber ME, Dressel A, Riffel J, Triem S, Lehmann M, Kopecky C, Säemann MD, Lepper PM, Silbernagel G, Scharnagl H, Ritsch A, Thorand B, de las Heras Gala T, Wagenpfeil S, Koenig W, Peters A, Laufs U, Wanner C, Fliser D, Speer T, März W.

Eur Heart J. 2015 Nov 14;36(43):3007-16. doi: 10.1093/eurheartj/ehv352. Epub 2015 Aug 6.

PMID:
26248570
16.

HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype.

Shroff R, Speer T, Colin S, Charakida M, Zewinger S, Staels B, Chinetti-Gbaguidi G, Hettrich I, Rohrer L, O'Neill F, McLoughlin E, Long D, Shanahan CM, Landmesser U, Fliser D, Deanfield JE.

J Am Soc Nephrol. 2014 Nov;25(11):2658-68. doi: 10.1681/ASN.2013111212. Epub 2014 May 22.

17.

Carbamylated low-density lipoprotein induces endothelial dysfunction.

Speer T, Owala FO, Holy EW, Zewinger S, Frenzel FL, Stähli BE, Razavi M, Triem S, Cvija H, Rohrer L, Seiler S, Heine GH, Jankowski V, Jankowski J, Camici GG, Akhmedov A, Fliser D, Lüscher TF, Tanner FC.

Eur Heart J. 2014 Nov 14;35(43):3021-32. doi: 10.1093/eurheartj/ehu111. Epub 2014 Mar 21.

18.

HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.

Zewinger S, Speer T, Kleber ME, Scharnagl H, Woitas R, Lepper PM, Pfahler K, Seiler S, Heine GH, März W, Silbernagel G, Fliser D.

J Am Soc Nephrol. 2014 May;25(5):1073-82. doi: 10.1681/ASN.2013050482. Epub 2014 Mar 7.

19.

Mycobacterium fortuitum peritonitis in peritoneal dialysis and its effects on the peritoneum.

Zewinger S, Meier CM, Fliser D, Klingele M.

Clin Nephrol. 2014 Nov;82(5):341-6. doi: 10.5414/CN107704.

PMID:
23673231
20.

Uraemic dyslipidaemia revisited: role of high-density lipoprotein.

Speer T, Zewinger S, Fliser D.

Nephrol Dial Transplant. 2013 Oct;28(10):2456-63. doi: 10.1093/ndt/gft080. Epub 2013 May 3. Review.

PMID:
23645475
21.

Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.

Speer T, Rohrer L, Blyszczuk P, Shroff R, Kuschnerus K, Kränkel N, Kania G, Zewinger S, Akhmedov A, Shi Y, Martin T, Perisa D, Winnik S, Müller MF, Sester U, Wernicke G, Jung A, Gutteck U, Eriksson U, Geisel J, Deanfield J, von Eckardstein A, Lüscher TF, Fliser D, Bahlmann FH, Landmesser U.

Immunity. 2013 Apr 18;38(4):754-68. doi: 10.1016/j.immuni.2013.02.009. Epub 2013 Mar 7.

22.

Supplemental Content

Loading ...
Support Center